Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.
Identifieur interne : 000584 ( Main/Exploration ); précédent : 000583; suivant : 000585Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.
Auteurs : O. Bondestam [Suède] ; L. Gahnberg ; M L Sund ; L. LinderSource :
- Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry [ 0275-1879 ]
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antibactériens (administration et posologie), Antibactériens (usage thérapeutique), Caries dentaires (prévention et contrôle), Caries dentaires (étiologie), Chlorhexidine (administration et posologie), Chlorhexidine (usage thérapeutique), Débit sécrétoire (MeSH), Femelle (MeSH), Gels (MeSH), Humains (MeSH), Mâle (MeSH), Neuroleptiques (effets indésirables), Numération de colonies microbiennes (MeSH), Salivation (effets des médicaments et des substances chimiques), Salive (microbiologie), Salive (métabolisme), Soins dentaires pour malades chroniques (MeSH), Statistique non paramétrique (MeSH), Streptococcus mutans (effets des médicaments et des substances chimiques), Streptococcus mutans (isolement et purification), Sujet âgé (MeSH), Troubles mentaux (traitement médicamenteux), Xérostomie (complications), Xérostomie (induit chimiquement), Xérostomie (microbiologie).
- MESH :
- administration et posologie : Antibactériens, Chlorhexidine.
- effets des médicaments et des substances chimiques : Salivation, Streptococcus mutans.
- effets indésirables : Neuroleptiques, Xérostomie.
- induit chimiquement : Xérostomie.
- isolement et purification : Streptococcus mutans.
- microbiologie : Salive, Xérostomie.
- métabolisme : Salive.
- prévention et contrôle : Caries dentaires.
- traitement médicamenteux : Troubles mentaux.
- usage thérapeutique : Antibactériens, Chlorhexidine.
- étiologie : Caries dentaires.
- Adulte, Adulte d'âge moyen, Débit sécrétoire, Femelle, Gels, Humains, Mâle, Numération de colonies microbiennes, Soins dentaires pour malades chroniques, Statistique non paramétrique, Sujet âgé.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Anti-Bacterial Agents (administration & dosage), Anti-Bacterial Agents (therapeutic use), Antipsychotic Agents (adverse effects), Chlorhexidine (administration & dosage), Chlorhexidine (therapeutic use), Colony Count, Microbial (MeSH), Dental Care for Chronically Ill (MeSH), Dental Caries (etiology), Dental Caries (prevention & control), Female (MeSH), Gels (MeSH), Humans (MeSH), Male (MeSH), Mental Disorders (drug therapy), Middle Aged (MeSH), Saliva (metabolism), Saliva (microbiology), Salivation (drug effects), Secretory Rate (MeSH), Statistics, Nonparametric (MeSH), Streptococcus mutans (drug effects), Streptococcus mutans (isolation & purification), Xerostomia (chemically induced), Xerostomia (complications), Xerostomia (microbiology).
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents, Chlorhexidine.
- chemical , adverse effects : Antipsychotic Agents.
- chemical , therapeutic use : Anti-Bacterial Agents, Chlorhexidine.
- chemically induced : Xerostomia.
- complications : Xerostomia.
- drug effects : Salivation, Streptococcus mutans.
- drug therapy : Mental Disorders.
- etiology : Dental Caries.
- isolation & purification : Streptococcus mutans.
- metabolism : Saliva.
- microbiology : Saliva, Xerostomia.
- prevention & control : Dental Caries.
- Adult, Aged, Colony Count, Microbial, Dental Care for Chronically Ill, Female, Gels, Humans, Male, Middle Aged, Secretory Rate, Statistics, Nonparametric.
Abstract
The potential pathogenic role of mutans streptococci in the etiology of dental caries is well-documented. Mutans streptococci are sensitive to chlorhexidine (CHX), and several methods for the clinical use of CHX have been described. An important target group for caries-preventive measures is patients with impaired salivary secretion due to the use of therapeutic drugs such as psychotropics. The aim of the present study was to compare two methods for antimicrobial treatment in such patients. Twenty-four volunteering patients at a hospital clinic were randomly divided into three groups: Group A, in which each participant was treated with 10% CHX gel in gel trays on two consecutive days, followed by application of a fluoride varnish; Group B, in which the patients were treated with the same CHX gel as above; and Group C, which was used as a control. After treatment, there was a reduction of mutans streptococci in the two groups treated with CHX. In group A, the sames collected one, three, and five weeks after the treatment were significantly lower than baseline values. No clearcut reduction of the number of mutans streptococci was observed in the subjects not treated with CHX. These data indicate that treatment with CHX gel in gel trays is superior to polishing the teeth with CHX gel. From a clinical point of view, our observations suggest that it is important to monitor the effect of antimicrobial treatment individually in order to optimize preventive programs in patients with impaired salivary secretion.
DOI: 10.1111/j.1754-4505.1996.tb00845.x
PubMed: 9084325
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.</title><author><name sortKey="Bondestam, O" sort="Bondestam, O" uniqKey="Bondestam O" first="O" last="Bondestam">O. Bondestam</name><affiliation wicri:level="1"><nlm:affiliation>Public Dental Health Services, County of Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Public Dental Health Services, County of Uppsala</wicri:regionArea><wicri:noRegion>County of Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Gahnberg, L" sort="Gahnberg, L" uniqKey="Gahnberg L" first="L" last="Gahnberg">L. Gahnberg</name></author><author><name sortKey="Sund, M L" sort="Sund, M L" uniqKey="Sund M" first="M L" last="Sund">M L Sund</name></author><author><name sortKey="Linder, L" sort="Linder, L" uniqKey="Linder L" first="L" last="Linder">L. Linder</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1996">1996 May-Jun</date><idno type="RBID">pubmed:9084325</idno><idno type="pmid">9084325</idno><idno type="doi">10.1111/j.1754-4505.1996.tb00845.x</idno><idno type="wicri:Area/Main/Corpus">000588</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000588</idno><idno type="wicri:Area/Main/Curation">000588</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000588</idno><idno type="wicri:Area/Main/Exploration">000588</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.</title><author><name sortKey="Bondestam, O" sort="Bondestam, O" uniqKey="Bondestam O" first="O" last="Bondestam">O. Bondestam</name><affiliation wicri:level="1"><nlm:affiliation>Public Dental Health Services, County of Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Public Dental Health Services, County of Uppsala</wicri:regionArea><wicri:noRegion>County of Uppsala</wicri:noRegion></affiliation></author><author><name sortKey="Gahnberg, L" sort="Gahnberg, L" uniqKey="Gahnberg L" first="L" last="Gahnberg">L. Gahnberg</name></author><author><name sortKey="Sund, M L" sort="Sund, M L" uniqKey="Sund M" first="M L" last="Sund">M L Sund</name></author><author><name sortKey="Linder, L" sort="Linder, L" uniqKey="Linder L" first="L" last="Linder">L. Linder</name></author></analytic><series><title level="j">Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry</title><idno type="ISSN">0275-1879</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Anti-Bacterial Agents (administration & dosage)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Antipsychotic Agents (adverse effects)</term><term>Chlorhexidine (administration & dosage)</term><term>Chlorhexidine (therapeutic use)</term><term>Colony Count, Microbial (MeSH)</term><term>Dental Care for Chronically Ill (MeSH)</term><term>Dental Caries (etiology)</term><term>Dental Caries (prevention & control)</term><term>Female (MeSH)</term><term>Gels (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Mental Disorders (drug therapy)</term><term>Middle Aged (MeSH)</term><term>Saliva (metabolism)</term><term>Saliva (microbiology)</term><term>Salivation (drug effects)</term><term>Secretory Rate (MeSH)</term><term>Statistics, Nonparametric (MeSH)</term><term>Streptococcus mutans (drug effects)</term><term>Streptococcus mutans (isolation & purification)</term><term>Xerostomia (chemically induced)</term><term>Xerostomia (complications)</term><term>Xerostomia (microbiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antibactériens (administration et posologie)</term><term>Antibactériens (usage thérapeutique)</term><term>Caries dentaires (prévention et contrôle)</term><term>Caries dentaires (étiologie)</term><term>Chlorhexidine (administration et posologie)</term><term>Chlorhexidine (usage thérapeutique)</term><term>Débit sécrétoire (MeSH)</term><term>Femelle (MeSH)</term><term>Gels (MeSH)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Neuroleptiques (effets indésirables)</term><term>Numération de colonies microbiennes (MeSH)</term><term>Salivation (effets des médicaments et des substances chimiques)</term><term>Salive (microbiologie)</term><term>Salive (métabolisme)</term><term>Soins dentaires pour malades chroniques (MeSH)</term><term>Statistique non paramétrique (MeSH)</term><term>Streptococcus mutans (effets des médicaments et des substances chimiques)</term><term>Streptococcus mutans (isolement et purification)</term><term>Sujet âgé (MeSH)</term><term>Troubles mentaux (traitement médicamenteux)</term><term>Xérostomie (complications)</term><term>Xérostomie (induit chimiquement)</term><term>Xérostomie (microbiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Chlorhexidine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Chlorhexidine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term><term>Chlorhexidine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Salivation</term><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Mental Disorders</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Salivation</term><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Neuroleptiques</term><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dental Caries</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Saliva</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Salive</term><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Saliva</term><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Salive</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Dental Caries</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Caries dentaires</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Troubles mentaux</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Chlorhexidine</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Caries dentaires</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Colony Count, Microbial</term><term>Dental Care for Chronically Ill</term><term>Female</term><term>Gels</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Secretory Rate</term><term>Statistics, Nonparametric</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Débit sécrétoire</term><term>Femelle</term><term>Gels</term><term>Humains</term><term>Mâle</term><term>Numération de colonies microbiennes</term><term>Soins dentaires pour malades chroniques</term><term>Statistique non paramétrique</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The potential pathogenic role of mutans streptococci in the etiology of dental caries is well-documented. Mutans streptococci are sensitive to chlorhexidine (CHX), and several methods for the clinical use of CHX have been described. An important target group for caries-preventive measures is patients with impaired salivary secretion due to the use of therapeutic drugs such as psychotropics. The aim of the present study was to compare two methods for antimicrobial treatment in such patients. Twenty-four volunteering patients at a hospital clinic were randomly divided into three groups: Group A, in which each participant was treated with 10% CHX gel in gel trays on two consecutive days, followed by application of a fluoride varnish; Group B, in which the patients were treated with the same CHX gel as above; and Group C, which was used as a control. After treatment, there was a reduction of mutans streptococci in the two groups treated with CHX. In group A, the sames collected one, three, and five weeks after the treatment were significantly lower than baseline values. No clearcut reduction of the number of mutans streptococci was observed in the subjects not treated with CHX. These data indicate that treatment with CHX gel in gel trays is superior to polishing the teeth with CHX gel. From a clinical point of view, our observations suggest that it is important to monitor the effect of antimicrobial treatment individually in order to optimize preventive programs in patients with impaired salivary secretion.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9084325</PMID><DateCompleted><Year>1997</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0275-1879</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><MedlineDate>1996 May-Jun</MedlineDate></PubDate></JournalIssue><Title>Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry</Title><ISOAbbreviation>Spec Care Dentist</ISOAbbreviation></Journal><ArticleTitle>Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.</ArticleTitle><Pagination><MedlinePgn>123-7</MedlinePgn></Pagination><Abstract><AbstractText>The potential pathogenic role of mutans streptococci in the etiology of dental caries is well-documented. Mutans streptococci are sensitive to chlorhexidine (CHX), and several methods for the clinical use of CHX have been described. An important target group for caries-preventive measures is patients with impaired salivary secretion due to the use of therapeutic drugs such as psychotropics. The aim of the present study was to compare two methods for antimicrobial treatment in such patients. Twenty-four volunteering patients at a hospital clinic were randomly divided into three groups: Group A, in which each participant was treated with 10% CHX gel in gel trays on two consecutive days, followed by application of a fluoride varnish; Group B, in which the patients were treated with the same CHX gel as above; and Group C, which was used as a control. After treatment, there was a reduction of mutans streptococci in the two groups treated with CHX. In group A, the sames collected one, three, and five weeks after the treatment were significantly lower than baseline values. No clearcut reduction of the number of mutans streptococci was observed in the subjects not treated with CHX. These data indicate that treatment with CHX gel in gel trays is superior to polishing the teeth with CHX gel. From a clinical point of view, our observations suggest that it is important to monitor the effect of antimicrobial treatment individually in order to optimize preventive programs in patients with impaired salivary secretion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bondestam</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Public Dental Health Services, County of Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gahnberg</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sund</LastName><ForeName>M L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Linder</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spec Care Dentist</MedlineTA><NlmUniqueID>8103755</NlmUniqueID><ISSNLinking>0275-1879</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005782">Gels</NameOfSubstance></Chemical><Chemical><RegistryNumber>R4KO0DY52L</RegistryNumber><NameOfSubstance UI="D002710">Chlorhexidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002710" MajorTopicYN="N">Chlorhexidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015169" MajorTopicYN="N">Colony Count, Microbial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017742" MajorTopicYN="N">Dental Care for Chronically Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003731" MajorTopicYN="N">Dental Caries</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005782" MajorTopicYN="N">Gels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012472" MajorTopicYN="N">Salivation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012636" MajorTopicYN="N">Secretory Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013295" MajorTopicYN="N">Streptococcus mutans</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014987" MajorTopicYN="N">Xerostomia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9084325</ArticleId><ArticleId IdType="doi">10.1111/j.1754-4505.1996.tb00845.x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suède</li></country></list><tree><noCountry><name sortKey="Gahnberg, L" sort="Gahnberg, L" uniqKey="Gahnberg L" first="L" last="Gahnberg">L. Gahnberg</name><name sortKey="Linder, L" sort="Linder, L" uniqKey="Linder L" first="L" last="Linder">L. Linder</name><name sortKey="Sund, M L" sort="Sund, M L" uniqKey="Sund M" first="M L" last="Sund">M L Sund</name></noCountry><country name="Suède"><noRegion><name sortKey="Bondestam, O" sort="Bondestam, O" uniqKey="Bondestam O" first="O" last="Bondestam">O. Bondestam</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000584 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000584 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:9084325
|texte= Effect of chlorhexidine gel treatment on the prevalence of mutans streptococci and lactobacilli in patients with impaired salivary secretion rate.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:9084325" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |